Martin Shkreli, once called America's most hated executive after raising prices on a key medicine, has gained many followers on X with his sharp pharma comments. He recently attacked Vinay Prasad, the new FDA Center for Biologics leader, calling him "nuts" with "no idea" about how the drug industry works. Prasad, an oncologist known for opposing COVID-19 booster shots, wrote that more testing should happen before changing vaccine rules.
Shkreli claims he talked with leaders of almost every major drug company recently, warning they might fail under Prasad's leadership. He fears stricter testing rules will harm companies already facing tough competition. Bristol Myers Squibb laid off 516 workers last month, bringing this year's total to 806 after cutting 2,200 jobs last year.
Some see Shkreli's criticism as proof Prasad stands up to drug companies, but others view it as a warning about industry troubles. The debate raises questions about whether struggling companies should survive or fail as part of normal market forces.
Shkreli claims he talked with leaders of almost every major drug company recently, warning they might fail under Prasad's leadership. He fears stricter testing rules will harm companies already facing tough competition. Bristol Myers Squibb laid off 516 workers last month, bringing this year's total to 806 after cutting 2,200 jobs last year.
Some see Shkreli's criticism as proof Prasad stands up to drug companies, but others view it as a warning about industry troubles. The debate raises questions about whether struggling companies should survive or fail as part of normal market forces.
